Literature DB >> 24855271

Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.

Yusuke Sato1, Shigekatsu Maekawa2, Ryohei Ishii3, Masashi Sanada4, Teppei Morikawa5, Yuichi Shiraishi6, Kenichi Yoshida4, Yasunobu Nagata4, Aiko Sato-Otsubo4, Tetsuichi Yoshizato4, Hiromichi Suzuki4, Yusuke Shiozawa4, Keisuke Kataoka4, Ayana Kon4, Kosuke Aoki4, Kenichi Chiba6, Hiroko Tanaka7, Haruki Kume2, Satoru Miyano8, Masashi Fukayama5, Osamu Nureki3, Yukio Homma9, Seishi Ogawa10.   

Abstract

Cushing's syndrome is caused by excess cortisol production from the adrenocortical gland. In corticotropin-independent Cushing's syndrome, the excess cortisol production is primarily attributed to an adrenocortical adenoma, in which the underlying molecular pathogenesis has been poorly understood. We report a hotspot mutation (L206R) in PRKACA, which encodes the catalytic subunit of cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA), in more than 50% of cases with adrenocortical adenomas associated with corticotropin-independent Cushing's syndrome. The L206R PRKACA mutant abolished its binding to the regulatory subunit of PKA (PRKAR1A) that inhibits catalytic activity of PRKACA, leading to constitutive, cAMP-independent PKA activation. These results highlight the major role of cAMP-independent activation of cAMP/PKA signaling by somatic mutations in corticotropin-independent Cushing's syndrome, providing insights into the diagnosis and therapeutics of this syndrome.
Copyright © 2014, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24855271     DOI: 10.1126/science.1252328

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  71 in total

Review 1.  Protein kinase A defects and cortisol-producing adrenal tumors.

Authors:  Mihail Zilbermint; Constantine A Stratakis
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-06       Impact factor: 3.243

Review 2.  Genetics of adrenal diseases in 2014: Genetics improves understanding of adrenocortical tumours.

Authors:  Xavier Bertagna
Journal:  Nat Rev Endocrinol       Date:  2014-12-16       Impact factor: 43.330

Review 3.  Insights from exome sequencing for endocrine disorders.

Authors:  Christiaan de Bruin; Andrew Dauber
Journal:  Nat Rev Endocrinol       Date:  2015-05-12       Impact factor: 43.330

4.  Cushing's syndrome mutant PKAL205R exhibits altered substrate specificity.

Authors:  Joshua M Lubner; Kimberly L Dodge-Kafka; Cathrine R Carlson; George M Church; Michael F Chou; Daniel Schwartz
Journal:  FEBS Lett       Date:  2017-02-03       Impact factor: 4.124

Review 5.  Genetics of Adrenocortical Development and Tumors.

Authors:  Maya Lodish
Journal:  Endocrinol Metab Clin North Am       Date:  2017-02-22       Impact factor: 4.741

Review 6.  Development of adrenal cortex zonation.

Authors:  Yewei Xing; Antonio M Lerario; William Rainey; Gary D Hammer
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06       Impact factor: 4.741

Review 7.  Genetics of Cushing's Syndrome.

Authors:  Laura C Hernández-Ramírez; Constantine A Stratakis
Journal:  Endocrinol Metab Clin North Am       Date:  2018-06       Impact factor: 4.741

Review 8.  Cushing's syndrome: from physiological principles to diagnosis and clinical care.

Authors:  Hershel Raff; Ty Carroll
Journal:  J Physiol       Date:  2015-01-05       Impact factor: 5.182

Review 9.  Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia.

Authors:  Morgan K Penny; Isabella Finco; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2016-12-08       Impact factor: 4.102

10.  Mutations of the Sonic Hedgehog Pathway Underlie Hypothalamic Hamartoma with Gelastic Epilepsy.

Authors:  Michael S Hildebrand; Nicole G Griffin; John A Damiano; Elisa J Cops; Rosemary Burgess; Ezgi Ozturk; Nigel C Jones; Richard J Leventer; Jeremy L Freeman; A Simon Harvey; Lynette G Sadleir; Ingrid E Scheffer; Heather Major; Benjamin W Darbro; Andrew S Allen; David B Goldstein; John F Kerrigan; Samuel F Berkovic; Erin L Heinzen
Journal:  Am J Hum Genet       Date:  2016-07-21       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.